Arizona Tribune - Boulevard

Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product

~ Supply Chain Now Fully Secure for PF614-MPAR ~

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, HUGE Biopharma Australia Pty Ltd., that the safety review committee recommends commencing dosing of the second cohort in its trial entitled "A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants." The safety review committee made this recommendation after reviewing safety and pharmacokinetic data from participants in the first cohort.

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals

MD+DI Names Babson Diagnostics, 2024 Medtech Company of the Year

MD+DI editors mark Babson Diagnostics as a notable true solution to deliver simplified blood testing through BetterWay.

Interactive Strength Inc. (Nasdaq:TRNR) Regains Full Compliance With Nasdaq Continued Listing Standards

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that the Company received a letter from the Staff at Nasdaq Listings Qualifications stating that the Company has regained compliance with Listing Rule 5550(a)(2), which specifies rules regarding a minimum bid price of $1.00.

InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 10

The Company announces that on 09 December 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.

Brainy, 'normal guy': the suspect in US insurance CEO's slaying

The suspect in the high-profile killing of a health insurance CEO that has gripped the United States graduated from an Ivy League university, reportedly hails from a wealthy family, and wrote social media posts brimming with cerebral musings.

Connected, brainy, athletic: the suspect in US insurance CEO's slaying

The suspect in the high-profile killing of a health insurance CEO that has gripped the United States graduated from an Ivy League university, reportedly hails from a wealthy family, and wrote social media posts brimming with cerebral musings.

Suspect arrested after hunt for US insurance chief's killer

A 26-year-old man was arrested Monday over the targeted killing of a health insurance executive on the streets of New York, with police crediting a McDonald's employee in Pennsylvania who spotted a suspicious-looking customer.

French film director denies child actor abuse in landmark trial

A French filmmaker accused of sexually assaulting actor Adele Haenel when she was 12 denied the charges Monday as his trial opened in Paris, five years after her allegations fired France's #MeToo movement.

Syria rebel leader discusses 'transfer of power' after Assad's fall

Syria's Islamist rebel leader on Monday began discussions on transferring power, a day after rebels dramatically unseated president Bashar al-Assad following decades of brutal rule.

Man questioned in case of murdered health exec

A man was being questioned Monday in connection with last week's killing of a top health insurance executive on a New York street, US media reported, as a nationwide hunt for the suspect continued.

Man questioned in case of murdered health exec: US media

A man was being questioned Monday in connection with last week's killing of a top health insurance executive on a New York street, US media reported, as a nationwide hunt for the suspect continued.

Beaten 'unconscious': police violence sparks outrage in Georgia

When Georgian protester Irakli Pipia started praying with a feeble voice, the policeman beating him drew closer to grasp what he was saying.

China probes Nvidia for 'violating' anti-monopoly law

China on Monday launched an investigation into US chip giant Nvidia for allegedly violating its anti-monopoly laws, a top government agency said, as the two countries race for global chipmaking dominance.

Despair grips Afghan women healthcare students facing ban

For Saja, studying nursing at a healthcare institute in Kabul was her last lifeline to make something of herself after women were banned from universities in Afghanistan two years ago.

French director accused of abusing star Haenel goes on trial

A French filmmaker accused of sexually assaulting actor Adele Haenel when she was 12 was to go on trial in Paris on Monday, five years after her allegations fired France's #MeToo movement.

Evacuations underway as Philippine volcano erupts

A volcano erupted in the central Philippines on Monday, sending a huge ash column high into the sky as the government ordered the evacuation of surrounding villages.

Trauma and terror of Kenya's kidnapped protesters

The Kenyan parliament was ablaze, protesters running through the streets, police firing into the crowds. Among them was John, who believed the unrest could bring about meaningful political change.

Australian police seek three suspects in 'terrorist' synagogue blaze

Australian police said Monday they are hunting for three suspects over an arson attack on a Melbourne synagogue, designating it a terrorist act.

Australian police seek three suspects in synagogue blaze

Australian police said on Monday they are hunting for three suspects over an arson attack on a Melbourne synagogue, which has been designated as a terrorist act.

Morpheus8 Newport Beach Doctor Helps Fade Wrinkles and Fine Lines

Orange County's leading Morpheus8 practitioner Dr. Brandon Richland, MD helps clients erase years off their appearance with Morpheus 8 face and body treatments. Experience a visible reduction of wrinkles and fine lines while achieving radiant improvement in skin texture and firmness.

Green Rise Foods to Present to Investors in Atlantic City

Green Rise Foods Inc. (TSXV:GRF and "Green Rise" or the "Company"), a grower of fresh produce in Controlled Environment Agriculture, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.

The Barber Shop Marketing’s Campaign for North Texas Giving Day Wins Prestigious Honors at the 9th Annual Shorty Impact Awards

The campaign to support North Texas Giving Day 2023, the nation's largest community-wide giving event, has been honored with two distinguished awards at the 9th Annual Shorty Impact Awards: the Bronze Honor in Fundraising Campaign and the coveted Audience Honor in Fundraising Campaign. The campaign was lead by North Texas-based advertising agency, The Barber Shop Marketing.

Protagonist Reports Final Results From Rusfertide Phase 2 REVIVE Study Showing Durable Hematocrit Control at the ASH 2024 Annual Meeting

54% of patients experience more than 2.5 years of durable hematocrit (Hct) control (

Registration Now Open for Specialty Coffee Expo Scheduled for April 25-27, 2025, in Houston, TX; Event is Produced by The Specialty Coffee Association

Over 17,000 Industry Professionals From 85 Countries Expected to Attend

TPT Global Tech Announces Plans to Restate Financial Statements and Files 8-K Report

TPT Global Tech, Inc. (the "Company"), a technology and telecommunications company, announced today its intention to restate certain previously issued financial statements. This decision follows a comprehensive review by the Company's management, and independent registered public accounting firm, Sadler, Gibb & Associates, LLC. Alongside this announcement, the Company has filed a Current Report on Form 8-K with the Securities and Exchange Commission (SEC) to provide further details.

CMP Recognized by Manage HR Magazine as a Top Outplacement Services Provider

Career Management Partners (CMP), a trusted leader in career transition services, has been recognized as a top Outplacement services provider by Manage HR Magazine. This award highlights CMP's innovative approach, which blends advanced technology and personalized coaching to deliver exceptional outcomes for organizations and their transitioning employees.

Global Licensing Group Highlights Commitment to Sustainability Excellence

Sharing key contributors, data-driven insights ignite eco-conscious results across the platform's leading events.

Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia

Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused on bone health and related areas, announced today it has granted Theramex the exclusive commercialization rights to ELADYNOS® (abaloparatide), a novel bone forming agent indicated for the treatment of osteoporosis in postmenopausal women and men at increased risk of fractures, for Mexico, Canada, Israel, South Africa, and Russia. Theramex will also have the opportunity to commercialize ELADYNOS® in other agreed upon unpartnered regions. Abaloparatide is marketed in the U.S. by Radius under the tradename TYMLOS®.

Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)

Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of CTD

Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5

Positive results in recent animal study strongly support first-ever human investigation for DehydraTECH-liraglutide

RIO	-1.17%	93.83	$
CMSC	0.87%	21.83	$
NGG	-2.94%	80.505	$
BTI	-1.58%	60.8	$
BCE	-0.91%	21.315	$
GSK	-2.45%	51.165	$
BCC	-2.17%	75.98	$
RYCEF	2.05%	19.5	$
JRI	0.06%	12.968	$
CMSD	0.64%	22.04	$
VOD	-1.57%	13.02	$
RBGPF	0.93%	65.61	$
BP	-1.83%	36.285	$
AZN	-3.06%	183.99	$
RELX	-0.51%	31.51	$

Arizona Tribune - Boulevard (English)

Featured

Hope fades, hunger sets in a week after Venezuela quakes

Trial begins for suspected mastermind of Malta journalist killing

Last news